Moreover, the global landscape of pharmaceutical intermediates is characterized by growing demand. The rise in chronic diseases, advancements in biotechnology, and the increasing need for personalized medicine are driving the need for more complex and diverse intermediates. As a result, companies are expanding their R&D efforts to discover new intermediates that can enhance the therapeutic profiles of existing drugs or lead to the development of entirely new classes of medications.
Ensuring the microbiological quality of water is essential, especially in industries like food and beverage, pharmaceutical, and cooling water systems. Disinfectants such as chlorine, ozone, and ultraviolet light are commonly used to eliminate harmful microorganisms. Biocides are used to control biological growth in systems like cooling towers and membrane processes, preventing fouling and contamination.
China has emerged as a powerhouse in the production of APIs, accounting for a significant portion of global supply. One of the primary reasons for this remarkable growth is the country's vast manufacturing capabilities, which benefit from relatively low labor costs and substantial government investment in the pharmaceutical sector. As a result, many Western pharmaceutical companies have increasingly turned to China to source their APIs, leading to a dramatic increase in imports over the past decade.